The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
02/16/2010
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-10-ARP-RDA
Opportunity Category:
Discretionary
Posted Date:
Feb 16, 2010
Creation Date:
Feb 16, 2010
Original Closing Date for Applications:
Jul 28, 2010
Current Closing Date for Applications:
Jul 28, 2010
Archive Date:
Aug 27, 2010
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
2
Estimated Total Program Funding:
$480,000
Award Ceiling:
$0
Award Floor:
$0
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The ARP Resource Development Award mechanism is being offered for the first time in FY10.
The ARP recognizes the critical need for improved resources to advance the field of ASD research and diagnosis, and to improve outcomes for individuals with ASD. The Resource Development Award supports product-driven research aimed at developing tools for use by the ASD research and/or clinical communities. These resources may include, but are not limited to, high-throughput assays, non-invasive imaging techniques, diagnostic tests, databases, devices, clinical tools, and model systems. Applicants should clearly articulate how the proposed product addresses an unmet need in the ASD research or clinical communities.
Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without Clinical Trials. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances.
Preliminary data relevant to the proposed product development is allowed, but not required. Preliminary data, unpublished results from the laboratory of the PI, research team, or collaborators named on this application, may be from outside of the ASD research field. Proposals should be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.
Resource Distribution Plan: A plan describing the means by which the fully developed resource will be made available to the scientific and/or clinical community at reasonable or appropriate administrative costs, such as costs required for packaging and shipping the resource, should be addressed in the application.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk
Synopsis Modification History
There are currently no modifications for this opportunity.
